Three more biotechs price their Nasdaq IPOs AgomAb, SpyGlass, and Veradermics have all set the terms for their IPOs this week, looking to raise somewhere between around $150m and $200m.

#AgomAbTherapeutics, #SpyGlassPharma, and #Veradermics have all set the terms for their initial pubic offerings on the #Nasdaq, looking to raise somewhere between $150 million and $200 million.

Additional Funding Raises: #Veradermics $150M Series C; #PhoenixEducationPartners $136M IPO; #GeneralIntuition $134M Seed; #Phablo.ai $125M Pre-Seed; #LangChain $125M Series B

Acquisitions: #AsteraLabs > #aiXscalePhotonics; #AuditBoard > #FairNow; #CairnsHealth > #TogeherbyRenee